M08.3 identifies seronegative polyarticular juvenile rheumatoid arthritis — inflammatory joint disease with five or more joints affected, onset before age 16, and negative rheumatoid factor on serologic testing.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 8
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M08.3.
Source · Editorial brief grounded in 5 cited references ↓
- Confirm and document negative rheumatoid factor (RF) test result by name and date — 'seronegative' must be supported by lab evidence, not assumed.
- Record that five or more distinct joints were affected within the first six months of symptom onset to satisfy the polyarticular threshold.
- Document patient age at onset; JIA diagnosis requires symptom onset before age 16 — include date of birth and date of first documented joint involvement.
- If Crohn's disease or ulcerative colitis is an associated condition, document the relationship explicitly so the Code Also instruction can be applied.
- Note which joints are involved by name to support medical necessity for any joint-specific procedures billed alongside M08.3.
Related CPT procedures
Procedure codes commonly billed with M08.3. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M08.3 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M08.3 when RF status is positive — positive RF maps to seropositive juvenile arthritis under M08.0- subcategories, not M08.3.
- Confusing polyarticular (5+ joints, M08.3) with pauciarticular (fewer than 5 joints, M08.4) — joint count must be documented to select the correct subtype.
- Omitting the Code Also entry for an associated IBD diagnosis (K50.- or K51.-) when inflammatory bowel disease is documented in the same encounter.
- Applying M08.3 to adult patients — this category is limited to onset before age 16; adult seronegative polyarthritis should be coded from M06.- or M13.- as appropriate.
- Bypassing the M08 Excludes1 list and coding M08.3 alongside psoriatic juvenile arthropathy (L40.54) or juvenile dermatomyositis (M33.0-), which are mutually exclusive.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
Use M08.3 when the medical record documents polyarticular juvenile idiopathic arthritis (JIA) with a confirmed negative rheumatoid factor (RF). 'Polyarticular' means five or more joints are involved during the first six months of disease. The seronegative distinction is clinically and diagnostically significant: seronegative polyarticular JIA has a different prognosis and treatment trajectory than seropositive disease (M08.0-), systemic-onset JIA (M08.2-), or pauciarticular JIA (M08.4). Do not use M08.3 if RF status is undocumented or positive.
M08.3 sits at the category level with no further laterality or site subclassification — the code itself is the billable endpoint. If the patient also has an associated underlying condition such as Crohn's disease (K50.-) or ulcerative colitis (K51.-), the tabular instructions require a Code Also entry for that condition. Review the M08 Excludes1 list before coding: arthropathy in Whipple's disease (M14.8), Felty's syndrome (M05.0), juvenile dermatomyositis (M33.0-), and psoriatic juvenile arthropathy (L40.54) are all excluded from M08 and must be coded elsewhere.
For orthopedic settings, M08.3 is most relevant when a pediatric patient presents for joint-related procedures — synovectomy, joint aspiration, or physical therapy — driven by a confirmed JIA diagnosis managed in coordination with pediatric rheumatology. MS-DRG v43.0 groups this code under DRGs 545–547 (Connective Tissue Disorders with/without MCC/CC), which directly affects inpatient reimbursement weight.
Sibling codes
Other billable codes under M08 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Does M08.3 require a 7th character extension?
02What is the difference between M08.3 and M08.0-?
03Can M08.3 be used for an adult patient who was diagnosed with JIA as a child?
04Is M08.3 site-specific? Do I need to add additional codes for each affected joint?
05What MS-DRGs does M08.3 map to for inpatient claims?
06Can M08.3 be coded alongside psoriatic arthritis codes?
07When should I add a Code Also entry with M08.3?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M08-/M08.3
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M08.3
- 04unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/941651/all/M08_3___Juvenile_rheumatoid_polyarthritis__seronegative_
- 05icdlist.comhttps://icdlist.com/icd-10/M08.3
Mira Scribe
The Mira AI Scribe captures RF serologic result (negative), total joint count affected, documented age at onset, and any associated systemic conditions such as IBD. This prevents a seronegative-versus-seropositive miscoding, a missing Code Also for comorbid Crohn's or UC, and an audit flag from undocumented lab support for the 'seronegative' descriptor.
See how Mira captures M08.3 documentation